Miltenyi Biotec, GSK Enter Cell and Gene Therapy Development Partnership

GlaxoSmithKline and Miltenyi Biotec are partnering to develop a cell and gene therapy platform, the companies announced last week.

Their collaboration will focus on discovering new chimeric antigen-receptor T-cell based therapeutics, with an eye toward optimizing manufacture and delivery to support the development of novel therapies in oncology and rare diseases.